Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit

Clinical Therapeutics

Volumn 32, Issue 2, 2010, Pages 293-299

  Frei, Christopher R ^a,b   Attridge, Russell T ^a,b   Mortensen, Eric M ^b,c,d   Restrepo, Marcos I ^b,c,d   Yu, Yifan ^a,b   Oramasionwu, Christine U ^a,b   Ruiz, Jessica L ^a   Burgess, David S ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c Veterans Evidence Based Research Dissemination Implementation Center   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

antibiotics; bacterial pneumonia; community acquired pneumonia; guidelines; health outcomes; mortality

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY HOSPITAL; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LENGTH OF STAY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; ODDS RATIO; PATIENT ADMISSION; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649151752     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.02.006     Document Type: Article

References (22)

1. DeFrances C.J., Lucas C.A., Buie V.C., and Golosinskiy A. 2006 National Hospital Discharge Survey (2008), National Center for Health Statistics, Hyattsville, Md National Health Statistics Report no 5.
2. Kung H.C., Hoyert D.L., Xu J.Q., and Murphy S.L. Deaths: Final Data for 2005 vol. 56 (2008), National Center for Health Statistics, Hyattsville, Md National Vital Statistics Reports, no. 10.
3. Angus D.C., Marrie T.J., Obrosky D.S., et al. Severe community-acquired pneumonia: Use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med. 166 (2002) 717-723
4. Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 164 (2004) 637-644
5. Gleason P.P., Meehan T.P., Fine J.M., et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 159 (1999) 2562-2572
6. Kahn K.L., Rogers W.H., Rubenstein L.V., et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA. 264 (1990) 1969-1973
7. Mandell L.A., Wunderink R.G., Anzueto A., et al., Infectious Diseases Society of America, American Thoracic Society. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 44 Suppl 2 (2007) S27-S72
8. Bartlett J.G., Breiman R.F., Mandell L.A., File Jr. T.M., and Infectious Diseases Society of America. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis. 26 (1998) 811-838
9. Bartlett J.G., Dowell S.F., Mandell L.A., et al., Infectious Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 31 (2000) 347-382
10. Benenson R., Magalski A., Cavanaugh S., and Williams E. Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad Emerg Med. 6 (1999) 1243-1248
11. Capelastegui A., Espana P.P., Quintana J.M., et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: A controlled beforeand-after design study. Clin Infect Dis. 39 (2004) 955-963
12. Dean N.C., Silver M.P., Bateman K.A., et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med. 110 (2001) 451-457
13. Fine M.J., Stone R.A., Lave J.R., et al. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: A randomized controlled trial. Am J Med. 115 (2003) 343-351
14. Marrie T.J., Lau C.Y., Wheeler S.L., et al., CAPITAL Study Investigators. A controlled trial of a critical pathway for treatment of communityacquired pneumonia. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 283 (2000) 749-755
15. Marrie T.J., and Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: A prospective study of patients not initially admitted to the ICU. Chest. 127 (2005) 1260-1270
16. Menéndez R., Ferrando D., Vallés J.M., and Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest. 122 (2002) 612-617
17. Mortensen E.M., Restrepo M., Anzueto A., and Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 117 (2004) 726-731
18. Bodí M., Rodríguez A., Solé-Violán J., et al., Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Antibiotic prescription for community- acquired pneumonia in the intensive care unit: Impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis. 41 (2005) 1709-1716
19. Frei C.R., Restrepo M.I., Mortensen E.M., and Burgess D.S. Impact of guidelineconcordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 119 (2006) 865-871
20. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N EnglJ Med. 336 (1997) 243-250
21. Halm E.A., Fine M.J., Marrie T.J., et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: Implications for practice guidelines. JAMA. 279 (1998) 1452-1457
22. Menendez R., Torres A., Rodriguez de Castro F., et al. Reaching stability in community-acquired pneumonia: The effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 39 (2004) 1783-1790